| 000 | 00692nam a22002297a 4500 | ||
|---|---|---|---|
| 020 | _a9789351072720 | ||
| 082 |
_a615.19 _bSIO |
||
| 100 |
_aSilverman, Richard B. _9108556 |
||
| 245 |
_aThe organic chemistry of drug design and drug action _cRichard B. Silverman and Mark W. Holladay |
||
| 250 | _a3rd ed. | ||
| 260 |
_aAmsterdam: _bElsvier, _c2014. |
||
| 300 | _axviii, 517p. | ||
| 500 | _aPB | ||
| 504 | _ainclude index | ||
| 546 | _aEng | ||
| 650 |
_aPharmaceutical chemistry _9172420 |
||
| 650 |
_aBiorganic chemistry _9107977 |
||
| 650 |
_aMolecular pharmacology _9107750 |
||
| 650 |
_aDrugs - Design _9172421 |
||
| 700 |
_aHolladay, Mark W. (jt.auth.) _9108559 |
||
| 942 | _cBK | ||
| 999 |
_c73362 _d73362 |
||